Temel: early palliative care alongside chemotherapy improved quality of life, mood and survival in lung cancer
Patients newly diagnosed with metastatic lung cancer who saw a palliative care team from diagnosis had better quality of life, less depression, less aggressive end-of-life care and lived a median 2.7 months longer than those receiving oncology care alone.
At Massachusetts General Hospital, 151 patients with newly diagnosed metastatic non-small-cell lung cancer were randomised to early palliative care integrated with standard oncology care (monthly visits with a palliative care clinician) or to standard oncology care with palliative care only on request.
The primary endpoint, change in quality of life at 12 weeks (FACT-L), favoured early palliative care (98.0 vs 91.5). Fewer patients had depressive symptoms (16% vs 38%), fewer received aggressive end-of-life care (33% vs 54%), and median survival was 11.6 versus 8.9 months.
The survival signal overturned the assumption that palliative care shortens life and led ASCO to recommend concurrent palliative care for all patients with metastatic cancer from diagnosis.
- Quality of life at 12 weeks: FACT-L 98.0 vs 91.5 (p = 0.03)
- Depressive symptoms 16% vs 38% (p = 0.01)
- Aggressive end-of-life care 33% vs 54%; more patients documented resuscitation preferences
- Median overall survival 11.6 vs 8.9 months (p = 0.02) despite less chemotherapy near death
Palliative care is not what happens when treatment stops; it works best alongside cancer treatment from the start. Patients feel better, are less depressed and may live longer. Access remains the constraint: most of the world's patients never see a palliative care specialist.
- Single centre, unblinded, and survival was not the primary endpoint; later trials showed mixed survival effects
- Small sample; the survival difference was not confirmed in the larger 2017 Temel trial across cancers
- Requires trained palliative care workforce that most health systems lack
- Mechanism (symptom control, less futile chemotherapy, better decision-making) remains debated